Jan Peter Glossmann

Dose Intensity of Chemotherapy in Patients With Relapsed Hodgkin's Lymphoma

Andreas Josting, Horst Müller, Peter Borchmann et al. · Journal of Clinical Oncology · 2010 · 162 citations · Full text

Medicine, Oncology, Pharmacology +15

Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas

Stephan Baldus, Thomas K. Zirbes, Sabine Engel et al. · International Journal of Cancer · 1998 · 103 citations

Medicine, Oncology, Pathology +16

Immunoreactivity of Monoclonal Antibody BW835 Represents a Marker of Progression and Prognosis in Early Gastric Cancer

Stephan Baldus, Thomas K. Zirbes, Jan Peter Glossmann et al. · Oncology · 2001 · 27 citations

Medicine, Cancer Biology, Oncology +17

Treatment cost development of patients undergoing remission induction chemotherapy: a pharmacoeconomic analysis before and after introduction of posaconazole prophylaxis

Sebastian Heimann, Oliver A. Cornely, Maria J. G. T. Vehreschild et al. · Mycoses · 2013 · 15 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacology +14

The Use of Statins in Hematopoietic Stem Cell Transplantation

Alexander Shimabukuro‐Vornhagen, Jan Peter Glossmann, Tanja M. Liebig et al. · Current Stem Cell Research & Therapy · 2009 · 11 citations

Medicine, Hematology, Pharmacotherapy +17